#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4037524	B	Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay	Homo sapiens	67		cell-based format	Scientific Literature
2.	ALA4037525	P	Solubility of compound in fasted state simulated intestinal fluid measured after 4 hrs		33		small-molecule physicochemical format	Scientific Literature
3.	ALA4037526	A	Efflux ratio of passive permeability in MDCK2-MDR1 cells transduced with BacMam2-BCRP at 3 uM after 90 mins by Transwell assay	Canis lupus familiaris	26		cell-based format	Scientific Literature
4.	ALA4037527	A	Passive permeability in MDCK2-MDR1 cells transduced with BacMam2-BCRP at 3 uM after 90 mins by Transwell assay	Canis lupus familiaris	33		cell-based format	Scientific Literature
5.	ALA4037528	B	Antagonist activity at CXCR2 in human whole blood assessed as inhibition of GROalpha-stimulated CD11b upregulation preincubated for 15 mins followed by GROalpha stimulation measured after 15 mins by FITC-staining based FACS analysis	Homo sapiens	34		single protein format	Scientific Literature
6.	ALA4037529	A	Fraction unbound in Han-Wistar SOA rat model brain at 2 mg/kg administered via oral gavage by UPLC/MS/MS analysis	Rattus norvegicus	9		organism-based format	Scientific Literature
7.	ALA4037530	A	Fraction unbound in Han-Wistar SOA rat model blood at 2 mg/kg administered via oral gavage by UPLC/MS/MS analysis	Rattus norvegicus	9		organism-based format	Scientific Literature
8.	ALA4037531	A	Dose normalized AUC (0 to 7 hrs) in Han-Wistar SOA rat model blood at 2 mg/kg administered via oral gavage by UPLC/MS/MS analysis	Rattus norvegicus	9		organism-based format	Scientific Literature
9.	ALA4037532	A	Dose normalized AUC (0 to 7 hrs) in Han-Wistar SOA rat model brain at 2 mg/kg administered via oral gavage by UPLC/MS/MS analysis	Rattus norvegicus	9		organism-based format	Scientific Literature
10.	ALA4037533	A	Ratio of brain dose normalized AUC (0 to 7 hrs) to plasma dose normalized AUC (0 to 7 hrs), Kp of the compound in Han-Wistar SOA rat model at 2 mg/kg administered via oral gavage by UPLC/MS/MS analysis	Rattus norvegicus	9		organism-based format	Scientific Literature
11.	ALA4037534	A	Unbound brain-to-blood concentration ratio in Han-Wistar SOA rat model at 2 mg/kg administered via oral gavage by UPLC/MS/MS analysis	Rattus norvegicus	9		organism-based format	Scientific Literature
12.	ALA4037535	A	Clearance in Wistar rat blood at 1.01 mg/kg, iv measured up to 4 hrs post dose	Rattus norvegicus	1		organism-based format	Scientific Literature
13.	ALA4037536	A	Volume of distribution at steady state in Wistar rat at 1.01 mg/kg, iv measured up to 4 hrs post dose	Rattus norvegicus	1		organism-based format	Scientific Literature
14.	ALA4037537	A	Elimination half life in Wistar rat at 1.01 mg/kg, iv measured up to 4 hrs post dose	Rattus norvegicus	1		organism-based format	Scientific Literature
15.	ALA4037538	A	Dose normalized AUC (0 to infinity) in Wistar rat at 1.01 mg/kg, iv measured up to 4 hrs post dose	Rattus norvegicus	1		organism-based format	Scientific Literature
16.	ALA4037539	A	Tmax in Wistar rat at 2.38 mg/kg, po measured up to 4 hrs post dose	Rattus norvegicus	1		organism-based format	Scientific Literature
17.	ALA4037540	A	Cmax in Wistar rat at 2.38 mg/kg, po measured up to 4 hrs post dose	Rattus norvegicus	1		organism-based format	Scientific Literature
18.	ALA4037541	A	Dose normalized AUC (0 to infinity) in Wistar rat at 2.38 mg/kg, po measured up to 4 hrs post dose	Rattus norvegicus	1		organism-based format	Scientific Literature
19.	ALA4037542	A	Oral bioavailability in Wistar rat at 2.38 mg/kg measured up to 4 hrs after dose	Rattus norvegicus	1		organism-based format	Scientific Literature